Delivery Order SPE2DR25D2018-SPE2DR26FZ2A6
Award Date 3/31/26
Potential Completion Date 4/21/26
Potential Value $10K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $10,439.07 delivery order to AmerisourceBergen Drug Corp on March 6, 2026, for Tavalisse 100 mg tablets (60-count). The order is placed under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling supply of pharmaceutical products and medical supplies to military healthcare programs worldwide. The pricing is firm fixed...
- The Defense Logistics Agency issued a $10,439.07 delivery order to AmerisourceBergen Drug Corp on March 25, 2026, for 60 tablets of Tavalisse 100 mg, with an ultimate completion date of April 15, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which provides pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The...
- The Defense Logistics Agency issued a $10,439.07 delivery order to Amerisourcebergen Drug Corp on March 23, 2026, for Tavalisse 100 mg tablets (60-count units), with an ultimate completion date of April 13, 2026. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is...
- <p>The Defense Logistics Agency issued a $10,439.07 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for Tavalisse 100 mg tablets (60-count supply), with an ultimate completion date of March 27, 2026.</p> <p>The order is issued under the company's Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside applied.</p>
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 25, 2026, for Tavalisse 150 mg tablets (60-count), with a ceiling value of $10,367.76.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion is scheduled for March 18, 2026. The order is priced on a firm fixed-price basis with no set-aside applied.</p>
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 9, 2026, with a ceiling value of $10,439.07 for TAVALISSE 100 MG TABLET 60S, a pharmaceutical product. Place of performance is Conshohocken, PA 19428. The order is firm fixed price with an ultimate completion date of March 3, 2026. The delivery order was issued under the parent DLA Troop Support Medical indefinite delivery contract (SPE2DX), a global pharmaceutical support vehicle valued at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Tavalisse 150 mg tablets (60-count) with a contract ceiling value of $18,593.94. This competitively awarded, non-set-aside delivery order utilizes firm fixed price pricing and is scheduled for completion by October 3, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $10,439.07 to AmerisourceBergen Drug Corp for 60 tablets of Tavalisse 100 mg on January 2, 2026, with completion expected by January 26, 2026. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Tavalisse is an immunosuppressant medication used to treat immune thrombocytopenia, a blood disorder affecting...
- The Defense Logistics Agency awarded a $9,266.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for 60 tablets of Tavalisse 100 mg, a pharmaceutical product for immune thrombocytopenia treatment. The contract, which is a child order under a larger indefinite delivery vehicle, requires completion by November 19, 2025, and will be fulfilled at the contractor's Conshohocken, Pennsylvania facility. This delivery order was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Tavalisse 100 mg tablets (60-count) with a contract ceiling value of $20,878.16. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of February 19, 2026, and performance location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical,...